Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Sarobe

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|December 15, 2010
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10Nancy Díaz-Valdés, Lorea Manterola, Virginia Belsúe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 21, 2013
Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of toleranceRocío García de la Garza, Pablo Sarobe, Juana Merino, et al.
Cancer Research|May 20, 2017
Expansion of Tumor-Infiltrating CD8<sup>+</sup> T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell TherapySarita M Fernandez-Poma, Diego Salas-Benito, Teresa Lozano, et al.
Journal of Virology|January 19, 2007
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infectionEsther Larrea, José I Riezu-Boj, Lucía Gil-Guerrero, et al.
Journal of Hepatology|March 8, 2013
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CBruno Sangro, Carlos Gomez-Martin, Manuel de la Mata, et al.
Cell Reports|August 24, 2017
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated CytotoxicityMaria Gato-Cañas, Miren Zuazo, Hugo Arasanz, et al.
International Journal of Cancer|May 24, 2007
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gammaAinhoa Arina, Oihana Murillo, Sandra Hervás-Stubbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2015
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR StimulationTeresa Lozano, Lorea Villanueva, Maika Durántez, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigensLaura Arribillaga, Iciar Echeverria, Viriginia Belsue, et al.
Emerging Microbes & Infections|September 20, 2021
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responsesBelén Aparicio, Noelia Casares, Josune Egea, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|December 15, 2010
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10Nancy Díaz-Valdés, Lorea Manterola, Virginia Belsúe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 21, 2013
Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of toleranceRocío García de la Garza, Pablo Sarobe, Juana Merino, et al.
Cancer Research|May 20, 2017
Expansion of Tumor-Infiltrating CD8<sup>+</sup> T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell TherapySarita M Fernandez-Poma, Diego Salas-Benito, Teresa Lozano, et al.
Journal of Virology|January 19, 2007
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infectionEsther Larrea, José I Riezu-Boj, Lucía Gil-Guerrero, et al.
Journal of Hepatology|March 8, 2013
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CBruno Sangro, Carlos Gomez-Martin, Manuel de la Mata, et al.
Cell Reports|August 24, 2017
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated CytotoxicityMaria Gato-Cañas, Miren Zuazo, Hugo Arasanz, et al.
International Journal of Cancer|May 24, 2007
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gammaAinhoa Arina, Oihana Murillo, Sandra Hervás-Stubbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2015
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR StimulationTeresa Lozano, Lorea Villanueva, Maika Durántez, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigensLaura Arribillaga, Iciar Echeverria, Viriginia Belsue, et al.
Emerging Microbes & Infections|September 20, 2021
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responsesBelén Aparicio, Noelia Casares, Josune Egea, et al.
Pageof 9